Paul Metzinger - Bio Lab President CEO, Acting CFO, Director

CEO

Mr. Metzinger was the President and Chief Executive Officer of Vyta Corporationration from February 26, 1998 to May 6, 1998 and has served in that same capacity from December 1, 1998 to present. In addition, Mr. Metzinger was serving as acting Chief Financial Officer since February of 2007. He was a director since February 26, 1998. He has served as a Manager and Vice President of BioAgra since August 15, 2005. He served as the General Manager of NanoPierce Card from January 2000 to June 2003. Prior to becoming a director, Mr. Metzinger practiced securities law in Denver, Colorado for over 32 years since 2007.
Age 73
Tenure 17 years
Phone855-413-7030
Webhttps://www.limitlessx.com
Metzinger received his J.D. degree in 1967 from Creighton University Law School and his L.L.M. from Georgetown University in 1969.

Bio Lab Management Efficiency

The company has return on total asset (ROA) of (50.94) % which means that it has lost $50.94 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (173.55) %, meaning that it created substantial loss on money invested by shareholders. Bio Lab's management efficiency ratios could be used to measure how well Bio Lab manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 392.05 K in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Bio Lab Naturals has a current ratio of 1.01, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Bio Lab until it has trouble settling it off, either with new capital or with free cash flow. So, Bio Lab's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bio Lab Naturals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bio to invest in growth at high rates of return. When we think about Bio Lab's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

CEO Age

Alvaro GarciaCompania Cervecerias Unidas
N/A
Bernardo PaivaAmbev SA ADR
45
Hugo ZalazarCompania Cervecerias Unidas
N/A
Stephen ArcosCompania Cervecerias Unidas
N/A
Francisco DominguezCompania Cervecerias Unidas
59
Claudio MelendezCompania Cervecerias Unidas
N/A
Ronald BernsteinVector Group
67
Matias SubercaseauxCompania Cervecerias Unidas
N/A
Fernando MoraCompania Cervecerias Unidas
N/A
Ivan MenezesDiageo PLC ADR
65
Matias BebinCompania Cervecerias Unidas
N/A
Alvaro RomanCompania Cervecerias Unidas
N/A
Fernando SacchiCompania Cervecerias Unidas
59
Howard LorberVector Group
75
Pedro AguadoCompania Cervecerias Unidas
50
Domingo ManterolaCompania Cervecerias Unidas
39
Jean NetoAmbev SA ADR
50
Jose NasrallahCompania Cervecerias Unidas
58
Anand KripaluDiageo PLC ADR
59
Carlos DiazCompania Cervecerias Unidas
N/A
Francisco MackennaCompania Cervecerias Unidas
57
Limitless X Holdings Inc., a lifestyle agency, specializes in the spectrum of brand development, product development, digital advertising and marketing, and direct to consumer fulfillment. It operates in three verticals and has eco-system with a series of products and service-oriented businesses within each, focuses on the health and wellness, beauty and skincare, and CBD industries. BIO LAB operates under Advertising Agencies classification in the United States and is traded on PNK Exchange. Bio Lab Naturals [BLAB] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Bio Lab Naturals Leadership Team

Elected by the shareholders, the Bio Lab's board of directors comprises two types of representatives: Bio Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio Lab's management team and ensure that shareholders' interests are well served. Bio Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Hoback, Director
Herbert Neuhaus, Executive Vice President - Marketing and Technology, Director
Robert Shaw, Director
Paul Metzinger, President CEO, Acting CFO, Director

Bio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bio Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bio Lab

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Lab position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Lab will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Paychex could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Paychex when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Paychex - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Paychex to buy it.
The correlation of Paychex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Paychex moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Paychex moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Paychex can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Bio Lab Naturals information on this page should be used as a complementary analysis to other Bio Lab's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Bio OTC Stock

If you are still planning to invest in Bio Lab Naturals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Lab's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Correlations
Find global opportunities by holding instruments from different markets